Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist

Shawn Cross

CFO at Pacira BioSciences, Inc. (PCRX)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $1.5M

Reported trades

Filed Stock Type Shares Price Value Since
Apr 24SEC PCRXPacira BioSciences, Inc. Sell Plan 12,941105,341 held (−11%) $25.16 $326K +44.3%
Apr 22SEC PCRXPacira BioSciences, Inc. Sell Plan 7,714105,341 held (−7%) $25.14 $194K +44.4%
Apr 22SEC PCRXPacira BioSciences, Inc. Sell Plan 2,845105,341 held (−3%) $25.01 $71K +45.2%
Apr 22SEC PCRXPacira BioSciences, Inc. Sell Plan 1,500105,341 held (−1%) $25.01 $38K +45.2%
Dec 11SEC PCRXPacira BioSciences, Inc. Sell Plan 15,89656,250 held (−22%) $25.03 $398K +45.1%
Dec 11SEC PCRXPacira BioSciences, Inc. Sell Plan 9,10456,250 held (−14%) $25.14 $229K +44.4%
Nov 13SEC PCRXPacira BioSciences, Inc. Sell Plan 12,06056,250 held (−18%) $22.09 $266K +64.4%
  • Sell

    CFO Shawn Cross sold $326K of PCRX at $25.16 — pre-scheduled 10b5-1 plan sale.

  • Sell

    CFO Shawn Cross sold $194K of PCRX at $25.14 — pre-scheduled 10b5-1 plan sale.

  • Sell

    CFO Shawn Cross sold $71K of PCRX at $25.01 — pre-scheduled 10b5-1 plan sale.

  • Sell

    CFO Shawn Cross sold $38K of PCRX at $25.01 — pre-scheduled 10b5-1 plan sale.

  • Sell

    CFO Shawn Cross sold $398K of PCRX at $25.03 — pre-scheduled 10b5-1 plan sale.

  • Sell

    CFO Shawn Cross sold $229K of PCRX at $25.14 — pre-scheduled 10b5-1 plan sale.